Thomas Hughes | Page 7

Cloudflare sustains traction in 2024 and raises guidance, reaffirming the outlook for earnings to growth by 400% over the next four years.

Home Depot stock is rising after its Q3 results. New highs are likely to come soon and with them an outlook for another 12% gain this year; 25% more next...

The S&P 500 can hit 7,400 in 2025, driven by earnings growth and capital returns, supported by healthy labor markets and aided by easing headwinds.

Monday.com posted another solid quarter, showing improved leverage and growing shareholder value; the price pullback is a signal to buy.

DraftKings is gaining traction in key markets, growing user count and engagement metrics. Analysts are lifting targets in 2024 and point to a 20% upside.

The hottest markets following the Fed's 25 basis point rate cut weren't big tech but the small caps, confirming the sector rotation which began over the summer.

L3Harris Technologies partnership with Palantir will drive innovation and advancement in the defense industry, boosting revenue and earnings over time.

Take-Two Interactive Software turned a corner in 2024 and is on track to sustain top-line growth and return to profitability in calendar 2025.

Mercado Libre is leading growth in its region and among global peers, with a 35% gain in Q3 and solid growth expected to be sustained in 2025.

The S&P 500 will likely continue to trend higher under the Trump administration because of labor market health, consumer spending, and easing business headwinds

Insiders are buying these stocks and signaling a shift in the winds that can drive their stocks higher in 2025. Which one is right for your portfolio?

NXP Semiconductors has headwinds in 2024 to weigh on the stock price action; the headwinds are expected to diminish in 2025, allowing business growth to resume.

Super Micro Computers investors should expect volatility to continue in 2024, with short-interest high and institutions buying.

Microsoft had a strong quarter but trimmed guidance, causing shares to fall by 5%. The market is at a critical juncture and a technical buying opportunity.

Advanced Micro Devices price plunge is an opportunity for investors they shouldn't pass up. The long-term opportunity outweighs near-term market sentiment.

Cameco is well-positioned to deliver positive cash flow and improve shareholder value as demand for uranium grows. Rising uranium prices are aiding margins.

Delek Logistics Partners pays a high yield, over 10% with shares near a long-term low, and the insiders are buying it. Analysts and institutions also buy.

Texas Roadhouse had a solid quarter, producing wider margins and serving up leveraged earnings growth and a dividend worth owning.

Tractor Supply Company is a solid buy in retail. The stock trades at a discounted price despite the solid Q3 release, growth outlook, and capital return.

Defense stocks like Lockheed Martin and RTX can fly higher in 2025 because of cash flow, capital returns, and increasing shareholder value.

GE Aerospace shares pulled back into a buying opportunity; the question is how deep the correction may get before the buy-signal is triggered.

Verizon will deliver double-digit total returns in 2025 because of its dividend and growth outlook. Share prices could rise 10% to 35% by year's end.

Berkshire Hathaway is selling Bank of America shares and capping gains in 2024; sales are expected to continue and offset Bank of America buybacks.

Nuclear power has reached a critical mass with all three of the major data center hyperscalers investing in the technology.

Intuitive Surgical builds value for shareholders without using debt, growing its cash balance simultaneously and accelerating revenue growth in 2024.

Netflix's rally will continue because the company is growing and outpacing estimates, improving business quality, driving robust cash flow, and buying shares.

NuScale Power Company is perfectly positioned to benefit from a nuclear boom as demand for the technology reaches a critical mass.

UnitedHealth Group fell into a buying opportunity following the Q3 release, and the market reaction was vigorous, confirming support at a critical level.

Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results align with the trend.

Dividend Aristocrat Fastenal is on track to reclaim its all-time high and potentially set a new one this year as the diversified business model sustains growth.